What evidence is available to guide us in adding antiglycemic agents to intensify basal insulin therapy? What is the rationale for using a fixed ratio insulin-GLP- 1 RA combination formulation?

What evidence is available to guide us in adding antiglycemic agents to intensify basal insulin therapy? What is the rationale for using a fixed ratio insulin-GLP- 1 RA combination formulation?

What options and evidence are available to guide us in adding antiglycemic agents to intensify basal insulin therapy? What is the role and rationale for using a fixed ratio insulin-GLP- 1 RA combination formulation?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Chantal Mathieu, MD, PhD

Chantal Mathieu, MD, PhD

Professor of Medicine
Program Director of Biomedical Sciences
Katholieke Universiteit
Chair of Endocrinology
University Hospital Gasthuisberg
Leuven, Belgium